Innovation is creating amazing possibilities in medicine, including robotic surgery and using AI in clinical testing. It’s also driving new approaches to deal-making and investing as these new technologies emerge.
Highlights from the J.P. Morgan Healthcare Conference 2025
Video
2025年2月18日
Innovation Trends Evolving Health Care in 2025
Video
2025年2月18日
How Digital and AI Can Live Up to Its Transformative Potential
The health care industry is rapidly adapting to the impact of digital and AI. As this potential gains momentum, this panel explores how enterprises are constructing the infrastructure to support it and users are developing further technology to build on it.
Video
2025年2月18日
JPM 2025: Insights into the Week’s Biggest Stories
Merck CEO Rob Davis and Medtronic CEO Geoff Martha share their observations and insights after the J.P. Morgan Healthcare Conference, from medical advancements and M&A news to thoughts about the regulatory environment in the year ahead and more.
Video
2025年1月21日
The Trends Shaping Health Care in 2025
BCG’s Torben Danger expects companies to prioritize innovation, reduce costs, improve productivity, and increase M&A activity this year.
Video
2025年1月21日
A Bullish Year for Medtech?
BCG’s Vikram Aggarwal on why medtech leaders are shifting from cost-cutting to growth, productivity, and scaling GenAI in 2025.
Video
2025年1月21日
Striking the Right Balance in Biopharma
Leaders should look to leverage their investments in AI as they weigh innovation spending against a renewed focus on cost, says BCG’s Priya Chandran.
Video
2025年1月21日
Accelerating Innovation in Healthcare with GenAI
Thomas Senderovitz of Novo Nordisk shares the many existing and potential uses of GenAI in health care—from clinical report writing to molecule design.
Video
2025年1月21日
The Biopharma Trends Defining Innovation and Growth
Sabrina Kristic shares insights on how generative AI, groundbreaking therapies, and market-specific challenges are shaping the future of Europe's biopharmaceutical sector—and why growth strategies must adapt to evolving pressures.
Video
2025年1月21日
The 2025 Agenda for European Health Care Companies
European health care leaders are focusing on market fundamentals as they work to integrate AI, pursue innovation, and respond to regulatory changes, says BCG’s Thomas Delano.
Video
2025年1月21日
What’s Ahead for AI in Health Care?
Amalgam Rx’s Chris Bergstrom sees many opportunities for AI in patient care. Finding ways to ensure patient safety will spur more innovation and provider adoption.
Video
2025年1月21日
Avoiding Tunnel Vision in Health Care Leadership
Health care leaders must address today’s realities while staying focused on where they need to go in the future, says BCG’s Daniel Gorlin.
Video
2025年1月21日
In Health Care, the Case for Optimism
BCG’s Barry Rosenberg shares why M&A momentum, innovation for clinical and economic value, and people-centered leadership will shape this year in the field of health.
Video
2025年1月21日
How M&A Can Foster Innovation in Health Care
To spur innovation and compete for products in the early ideation phase, companies should set aside funding for acquisitions, licensing, and partnerships, says Baxter's John Ranz.
Video
2025年1月24日
Navigating AI to Improve Health Care
Providence’s Sara Vaezy discusses the challenges of today’s proliferation of AI solutions and how the technology can enhance patient and clinician experiences.
Video
2025年1月24日
The Breakthroughs and Trends that Will Shape Health Care in 2025
BCG's leading experts share what excites them most about the future of health care in 2025 and beyond.
Video
2025年1月24日
All Eyes on AI in the Ophthalmic Industry
New AI-based tools and techniques in the field of ophthalmology are transforming how doctors do their work and patients receive care, says Alcon’s Franck Leveiller.
Video
2025年1月24日
How Private Equity Can Reshape Health Care
With a significant amount of dry powder, private equity firms can influence how research happens and where therapies are deployed—and how quickly, says BCG’s Bob Lavoie.
Video
2025年1月24日
The Forces Reshaping Biopharma in 2025
BCG’s Ashkan Afkhami discusses GenAI’s impact on trial efficiency, the challenge of scaling innovation, and why partnerships are key to driving health care transformation this year.
Video
2025年1月29日
Innovations in Health Care Using GenAI
PSFC’s Dan Grossman explores health care’s biggest problems—such as aligning the needs of patients, providers, and payers—and how GenAI can help solve them.
Our Client Success
Learn more about BCG’s latest work with health care clients.
BCG and Zeiss developed an application to give prospective patients fast, accurate, validated answers about elective treatments.
LEARN MORE
LEARN MORE
How BCG used a cascaded and holistic organization-design approach to help a global biotech firm reduce its gross labor and non-labor costs by 20%.
LEARN MORE
LEARN MORE
BCG X partners to leverage new AI tools and platform to enhance clinical trials, speeding up medical innovations, life-changing therapies, and patient outcomes.
LEARN MORE
LEARN MORE
This year, BCG launched a collaboration with Merck aimed at advancing the discovery and assessment of novel drug targets for chronic and degenerative diseases through AI.
Meet Our Experts
Our Latest Thinking
Article
2024年9月24日
BCG’s second annual report reviews the growth of new drug modalities over the past year and addresses the potential impact on the biopharmaceutical industry.
Article
2024年1月4日
New GenAI offerings can benefit virtually every aspect of an organization, boosting efficiency and productivity in areas ranging from R&D to commercial activities.
Article
2023年9月12日
To realize the promise and potential for GenAI, medtech executives must make swift and targeted efforts.
Article
2024年5月23日
Costs for genomic sequencing have dropped steeply, making new types of genetic tests more accessible and changing the business model for the labs that run them.
Article
2024年10月30日
The rise of GenAI brings tremendous opportunity. But to cut through the hype and identify future winners, investors should focus on four innovation hot spots.
Article
2024年9月12日
グローバルなバイオ医薬品会社のデータ・テクノロジー最高責任者（CDTO）が、バリューチェーン全体にデジタル機能を導入し、患者の治療結果に注力することについて語ります。
